RPS Strategic Solutions Division, formerly RPS and now a division of PRA, delivers the customized services you need with our customized Embedded strategies designed to manage large and mid-size biopharmaceutical companies? pipeline portfolios more efficiently and with greater flexibility and control. We leverage the extensive experience of our team of professionals along with best practices acquired from our considerable market experience to bring innovative new approaches that enhance quality, streamline development processes and improve efficiency. RPS is uniquely positioned to provide the following customized clinical development solutions:
Large Organizations: RPS provides innovative, Embedded, portfolio-wide clinical development solutions delivering multi-million dollar cost savings, greater quality and the ability to manage more within their portfolio while retaining strategic control and effectively managing regulatory risk. Midsize Organizations: RPS has leveraged its market leading Embedded Clinical Development Solutions expertise providing an innovative model that enables the efficient internal development of a midsize company?s product portfolio with greater control and flexibility, accelerated development timelines and substantially reduced costs. Virtual/Specialty Organizations: Our Product Registration group executes complex, global Phase II-III studies for a variety of indications. Learn more about our Product Registration Services